76 related articles for article (PubMed ID: 2542863)
41. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
Hinai AA; Valk PJ
Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
[TBL] [Abstract][Full Text] [Related]
42. The EVI1 gene in myeloid leukemia.
Nucifora G
Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815
[TBL] [Abstract][Full Text] [Related]
43. [EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].
He XF; Wang QR; Cen JN; Qiu HY; Sun AN; Chen SN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):936-941. PubMed ID: 27995876
[TBL] [Abstract][Full Text] [Related]
44. Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR.
He X; Wang Q; Cen J; Qiu H; Sun A; Chen S; Wu D
Bone Marrow Transplant; 2016 Jul; 51(7):921-7. PubMed ID: 27042849
[TBL] [Abstract][Full Text] [Related]
45. Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia.
Juneja SC; Vonica A; Zeiss C; Lezon-Geyda K; Yatsula B; Sell DR; Monnier VM; Lin S; Ardito T; Eyre D; Reynolds D; Yao Z; Awad HA; Yu H; Wilson M; Honnons S; Boyce BF; Xing L; Zhang Y; Perkins AS
Bone; 2014 Mar; 60():148-61. PubMed ID: 24316420
[TBL] [Abstract][Full Text] [Related]
46. Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media.
Parkinson N; Hardisty-Hughes RE; Tateossian H; Tsai HT; Brooker D; Morse S; Lalane Z; MacKenzie F; Fray M; Glenister P; Woodward AM; Polley S; Barbaric I; Dear N; Hough TA; Hunter AJ; Cheeseman MT; Brown SD
PLoS Genet; 2006 Oct; 2(10):e149. PubMed ID: 17029558
[TBL] [Abstract][Full Text] [Related]
47. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; Sellers S; Holt IE; Eckfeldt CE; Sharma Y; Schmidt M; von Kalle C; Persons DA; Billings EM; Verfaillie CM; Nienhuis AW; Wolfsberg TG; Dunbar CE; Calmels B
PLoS Biol; 2004 Dec; 2(12):e423. PubMed ID: 15550989
[TBL] [Abstract][Full Text] [Related]
48. A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.
Valk PJ; Joosten M; Vankan Y; Löwenberg B; Delwel R
Nucleic Acids Res; 1997 Nov; 25(21):4419-21. PubMed ID: 9336478
[TBL] [Abstract][Full Text] [Related]
49. Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.
Nibbs RJ; Itoh K; Ostertag W; Harrison PR
Mol Cell Biol; 1993 Sep; 13(9):5582-92. PubMed ID: 8355701
[TBL] [Abstract][Full Text] [Related]
50. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
Kreider BL; Orkin SH; Ihle JN
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
[TBL] [Abstract][Full Text] [Related]
51. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
[TBL] [Abstract][Full Text] [Related]
52. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
Mitani K; Ogawa S; Tanaka T; Miyoshi H; Kurokawa M; Mano H; Yazaki Y; Ohki M; Hirai H
EMBO J; 1994 Feb; 13(3):504-10. PubMed ID: 8313895
[TBL] [Abstract][Full Text] [Related]
53. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
[TBL] [Abstract][Full Text] [Related]
54. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.
Ben-David Y; Giddens EB; Bernstein A
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1332-6. PubMed ID: 2304901
[TBL] [Abstract][Full Text] [Related]
55. Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene.
Matsugi T; Morishita K; Ihle JN
Mol Cell Biol; 1990 Mar; 10(3):1259-64. PubMed ID: 2106070
[TBL] [Abstract][Full Text] [Related]
56. A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross.
Justice MJ; Siracusa LD; Gilbert DJ; Heisterkamp N; Groffen J; Chada K; Silan CM; Copeland NG; Jenkins NA
Genetics; 1990 Aug; 125(4):855-66. PubMed ID: 1975791
[TBL] [Abstract][Full Text] [Related]
57. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
58. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
Morishita K; Parganas E; William CL; Whittaker MH; Drabkin H; Oval J; Taetle R; Valentine MB; Ihle JN
Proc Natl Acad Sci U S A; 1992 May; 89(9):3937-41. PubMed ID: 1570317
[TBL] [Abstract][Full Text] [Related]
59. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
Morishita K; Parganas E; Matsugi T; Ihle JN
Mol Cell Biol; 1992 Jan; 12(1):183-9. PubMed ID: 1370341
[TBL] [Abstract][Full Text] [Related]
60. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.
Bartholomew C; Morishita K; Askew D; Buchberg A; Jenkins NA; Copeland NG; Ihle JN
Oncogene; 1989 May; 4(5):529-34. PubMed ID: 2542863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
